TY - JOUR
T1 - Validation of the MD Anderson Symptom Inventory-Head-and-Neck -Filipino (MDASI-HN-F)
T2 - Clinical utility of symptom screening among patients with head-and-neck cancer
AU - Bacorro, Warren R.
AU - Ortin, Teresa T.Sy
AU - Suarez, Consuelo G.
AU - Mendoza, Tito R.
AU - Que, Jocelyn C.
PY - 2017/6
Y1 - 2017/6
N2 - Context Symptom burden and quality of life (QOL) are of particular importance in head-andneck cancer treatment. The MD Anderson Symptom Inventory-Head-and-Neck (MDASIHN) is a simple symptom assessment tool practicable for patient follow-up, but a validated Filipino translation was previously unavailable. Objectives The objectives of this study were to develop a valid Filipino translation of the MDASIHN, to test the sensitivity of the validated MDASI core-F, and to report the prevalence and pattern of head-and-neck symptoms in our cohort. Methods An MDASI-HN-Filipino (MDASI-HN-F) version was developed and examined for convergent validity, internal consistency, testretest reliability, known-group validity and sensitivity to change. Eligible participants were aged 18-80 years, with histopathologicallyproven head-and-neck (except thyroid) cancer, able to understand and read English and Filipino, and without cognitive impairment or other conditions precluding self-administration of the questionnaire. Results Participants (n=100) were aged 18- 76 years; the majority were aged < 60, male, married, had college schooling, or were from a Tagalog-speaking region. The validity of the MDASI HN-F was demonstrated in all parameters. Age or educational attainment did not affect convergent validity or test-retest reliability. At baseline, 48% had multiple moderate/severe symptoms and 38% had at least one severe symptom. Conclusions The MDASI-HN-F is valid, reliable and sensitive. The sensitivity of the MDASI core-F is demonstrated, and its validity and reliability reaffirmed. Moderate and severe head-and-neck symptoms are prevalent in early-stage and advanced-stage head-and-neck cancers, reflecting the utility of symptom screening for improvement of symptom management, QOL and compliance to treatment.
AB - Context Symptom burden and quality of life (QOL) are of particular importance in head-andneck cancer treatment. The MD Anderson Symptom Inventory-Head-and-Neck (MDASIHN) is a simple symptom assessment tool practicable for patient follow-up, but a validated Filipino translation was previously unavailable. Objectives The objectives of this study were to develop a valid Filipino translation of the MDASIHN, to test the sensitivity of the validated MDASI core-F, and to report the prevalence and pattern of head-and-neck symptoms in our cohort. Methods An MDASI-HN-Filipino (MDASI-HN-F) version was developed and examined for convergent validity, internal consistency, testretest reliability, known-group validity and sensitivity to change. Eligible participants were aged 18-80 years, with histopathologicallyproven head-and-neck (except thyroid) cancer, able to understand and read English and Filipino, and without cognitive impairment or other conditions precluding self-administration of the questionnaire. Results Participants (n=100) were aged 18- 76 years; the majority were aged < 60, male, married, had college schooling, or were from a Tagalog-speaking region. The validity of the MDASI HN-F was demonstrated in all parameters. Age or educational attainment did not affect convergent validity or test-retest reliability. At baseline, 48% had multiple moderate/severe symptoms and 38% had at least one severe symptom. Conclusions The MDASI-HN-F is valid, reliable and sensitive. The sensitivity of the MDASI core-F is demonstrated, and its validity and reliability reaffirmed. Moderate and severe head-and-neck symptoms are prevalent in early-stage and advanced-stage head-and-neck cancers, reflecting the utility of symptom screening for improvement of symptom management, QOL and compliance to treatment.
UR - http://www.scopus.com/inward/record.url?scp=85020801813&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020801813&partnerID=8YFLogxK
U2 - 10.1136/bmjspcare-2014-000787
DO - 10.1136/bmjspcare-2014-000787
M3 - Article
C2 - 25941198
AN - SCOPUS:85020801813
SN - 2045-435X
VL - 7
SP - 140
EP - 149
JO - BMJ Supportive and Palliative Care
JF - BMJ Supportive and Palliative Care
IS - 2
ER -